Dexcom (NDAQ:DXCM) Covered By Yet Another Research Firm

September 17, 2017 - By reb123z

 Dexcom (NDAQ:DXCM) Covered By Yet Another Research Firm

Investors sentiment increased to 1.37 in 2016 Q4. Its up 0.27, from 1.1 in 2016Q3. It improved, as 43 investors sold DexCom, Inc. shares while 81 reduced holdings. 68 funds opened positions while 102 raised stakes. 92.29 million shares or 4.94% more from 87.94 million shares in 2016Q3 were reported.

Gulf National Bank & Trust (Uk) Limited stated it has 29,470 shares. Trexquant Invest Limited Partnership owns 6,327 shares. Driehaus Mgmt Limited Co stated it has 8,705 shares or 0.02% of all its holdings. Price T Rowe Assoc Md has invested 0.05% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). Barclays Public Ltd Liability Company holds 0% in DexCom, Inc. (NASDAQ:DXCM) or 30,717 shares. Ibm Retirement Fund owns 6,590 shares. Quantbot Technology L P reported 17,650 shares. Mackenzie holds 0.35% or 982,689 shares. Acadian Asset Management Lc has 200 shares. Iguana Management Limited Liability Com holds 0.71% of its portfolio in DexCom, Inc. (NASDAQ:DXCM) for 20,000 shares. J&P(China)Capital Mgmt Coltd invested in 43,442 shares. Moreover, Raymond James Advisors has 0.01% invested in DexCom, Inc. (NASDAQ:DXCM). Ig Mngmt Limited holds 26,352 shares or 0.01% of its portfolio. Aqr Mgmt reported 66,074 shares stake. 5,820 are owned by Advisory Research.

Since March 17, 2017, it had 0 buys, and 10 selling transactions for $2.72 million activity. $304,006 worth of stock was sold by Pacelli Steven Robert on Thursday, March 23. Another trade for 3,200 shares valued at $220,989 was made by Balo Andrew K on Monday, June 12. DOUBLEDAY RICHARD sold $217,290 worth of stock or 3,182 shares. $778,158 worth of DexCom, Inc. (NASDAQ:DXCM) shares were sold by SAYER KEVIN R. $151,937 worth of DexCom, Inc. (NASDAQ:DXCM) shares were sold by ROPER JESS.

Why Has Barclays Capital Given Dexcom (NDAQ:DXCM) a $76.00 Price Target

In an analyst note issued on 15 September, Barclays Capital analyst has today has started coverage for Dexcom (NDAQ:DXCM) shares with a “Equal Weight” rating. The target is $76.00.

Investors sentiment increased to 1.37 in 2016 Q4. Its up 0.27, from 1.1 in 2016Q3. It improved, as 43 investors sold DexCom, Inc. shares while 81 reduced holdings. 68 funds opened positions while 102 raised stakes. 92.29 million shares or 4.94% more from 87.94 million shares in 2016Q3 were reported.

Gulf National Bank & Trust (Uk) Limited stated it has 29,470 shares. Trexquant Invest Limited Partnership owns 6,327 shares. Driehaus Mgmt Limited Co stated it has 8,705 shares or 0.02% of all its holdings. Price T Rowe Assoc Md has invested 0.05% of its portfolio in DexCom, Inc. (NASDAQ:DXCM). Barclays Public Ltd Liability Company holds 0% in DexCom, Inc. (NASDAQ:DXCM) or 30,717 shares. Ibm Retirement Fund owns 6,590 shares. Quantbot Technology L P reported 17,650 shares. Mackenzie holds 0.35% or 982,689 shares. Acadian Asset Management Lc has 200 shares. Iguana Management Limited Liability Com holds 0.71% of its portfolio in DexCom, Inc. (NASDAQ:DXCM) for 20,000 shares. J&P(China)Capital Mgmt Coltd invested in 43,442 shares. Moreover, Raymond James Advisors has 0.01% invested in DexCom, Inc. (NASDAQ:DXCM). Ig Mngmt Limited holds 26,352 shares or 0.01% of its portfolio. Aqr Mgmt reported 66,074 shares stake. 5,820 are owned by Advisory Research.

Since March 17, 2017, it had 0 buys, and 10 selling transactions for $2.72 million activity. $304,006 worth of stock was sold by Pacelli Steven Robert on Thursday, March 23. Another trade for 3,200 shares valued at $220,989 was made by Balo Andrew K on Monday, June 12. DOUBLEDAY RICHARD sold $217,290 worth of stock or 3,182 shares. $778,158 worth of DexCom, Inc. (NASDAQ:DXCM) shares were sold by SAYER KEVIN R. $151,937 worth of DexCom, Inc. (NASDAQ:DXCM) shares were sold by ROPER JESS.

DexCom, Inc. (NASDAQ:DXCM) Ratings Coverage

Among 4 analysts covering Dexcom (NDAQ:DXCM), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Dexcom has $90 highest and $87 lowest target. $88.50’s average target is 25.91% above currents $70.29 stock price. Dexcom had 4 analyst reports since March 23, 2017 according to SRatingsIntel. Oppenheimer maintained the shares of DXCM in report on Thursday, March 23 with “Buy” rating. Cowen & Co maintained the shares of DXCM in report on Wednesday, April 19 with “Outperform” rating. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Outperform” rating by William Blair on Friday, April 28. RBC Capital Markets maintained it with “Outperform” rating and $87 target in Wednesday, April 5 report.

The stock decreased 2.85% or $2.06 on September 15, reaching $70.29. About 824,870 shares traded. DexCom, Inc. (NDAQ:DXCM) has risen 9.41% since September 17, 2016 and is uptrending. It has underperformed by 7.29% the S&P500.

Analysts expect DexCom, Inc. (NASDAQ:DXCM) to report $-0.14 EPS on November, 7.They anticipate $0.08 EPS change or 36.36 % from last quarter’s $-0.22 EPS. After having $-0.16 EPS previously, DexCom, Inc.’s analysts see -12.50 % EPS growth.

Dexcom, Inc. is a medical device company. The company has market cap of $6.08 billion. The Firm is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. It currently has negative earnings. The Company’s products consist of DexCom G4 PLATINUM and DexCom G5 Mobile.

More notable recent DexCom, Inc. (NASDAQ:DXCM) news were published by: Nasdaq.com which released: “Why Is DexCom (DXCM) Up 11.6% Since the Last Earnings Report?” on September 01, 2017, also Seekingalpha.com with their article: “Why The Dexcom Deal Is Big For Fitbit” published on September 13, 2017, Marketwatch.com published: “Fitbit shares jump almost 10% on news to work with Dexcom on diabetes product” on September 07, 2017. More interesting news about DexCom, Inc. (NASDAQ:DXCM) were released by: Investorplace.com and their article: “Why Fitbit Inc (FIT) Stock Is Rising on the Latest Ionic Update” published on September 12, 2017 as well as Nasdaq.com‘s news article titled: “DexCom Breaks Below 200-Day Moving Average – Notable for DXCM” with publication date: September 07, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.